Equities
Health CareHealth Care Providers
  • Price (USD)78.48
  • Today's Change0.13 / 0.17%
  • Shares traded3.35m
  • 1 Year change+24.33%
  • Beta0.3831
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.

  • Revenue in USD (TTM)154.00bn
  • Net income in USD2.70bn
  • Incorporated2001
  • Employees67.70k
  • Location
    Centene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
  • Phone+1 (314) 725-4477
  • Fax+1 (302) 655-5049
  • Websitehttps://www.centene.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chemed Corp2.26bn272.51m9.70bn15.09k35.828.7129.114.2917.9217.92148.9973.691.46131.5914.11150,090.6017.5219.5321.7924.6435.2834.6012.0312.601.57--0.0148.156.064.909.175.801.466.10
Tenet Healthcare Corp20.55bn611.00m10.51bn78.14k18.026.534.820.51155.835.83196.0016.090.74098.806.58262,950.404.733.616.755.0982.5382.976.384.951.424.150.73150.007.172.3349.0241.424.01--
Davita Inc12.14bn691.54m12.11bn70.00k18.6311.617.110.99737.417.41130.2911.890.717965.975.89173,430.705.665.627.557.4531.4730.707.888.331.134.770.7536--4.571.2626.442.33-10.47--
Universal Health Services, Inc.14.28bn717.49m12.27bn73.35k17.801.999.530.858810.2510.25203.6691.531.04--6.71194,710.005.246.446.147.63----5.046.551.295.690.4426.066.595.806.32-1.471.1714.87
Quest Diagnostics Inc9.25bn850.00m14.74bn40.00k17.782.3411.161.597.497.4981.5256.820.688932.397.69231,300.006.579.287.5810.8133.1436.649.5312.971.208.470.423425.07-6.384.20-9.773.401.277.43
Laboratory Corporation of Amerc Holdings12.16bn379.20m18.37bn67.00k51.862.3319.181.514.214.65139.1193.860.659518.614.75181,516.402.066.272.497.3727.6732.333.139.511.025.890.3944--2.511.42-62.16-16.403.62--
Molina Healthcare Inc34.07bn1.09bn24.07bn18.00k21.855.6519.070.706418.8118.81587.2072.672.50--12.611,892,889.008.027.6217.9116.8015.8615.993.203.04--14.810.36140.006.5612.5237.759.0622.87--
Humana Inc106.37bn2.49bn41.80bn67.60k17.492.6112.070.392919.8319.83855.93133.052.36----1,573,580.005.657.57--------2.393.35--9.250.416712.5414.5413.33-11.307.6510.4113.25
Centene Corp154.00bn2.70bn41.98bn67.70k15.971.6210.460.27264.914.91282.1848.351.91--10.692,274,727.003.342.585.623.9911.2411.591.751.37--4.700.40720.006.5420.70124.7924.593.43--
HCA Healthcare Inc64.97bn5.24bn88.21bn220.00k17.57--9.621.3618.9818.98235.03-6.681.204.846.89295,309.1011.2111.9915.1215.7584.7684.109.3810.171.025.020.973910.547.866.84-7.1110.135.8311.38
Cigna Group195.27bn5.16bn106.18bn72.50k20.892.3012.630.543817.3917.39657.71158.031.3232.6411.182,693,310.003.624.095.205.5512.8913.982.753.610.65085.930.400213.698.1732.15-22.9714.4224.40161.81
Data as of Mar 28 2024. Currency figures normalised to Centene Corp's reporting currency: US Dollar USD

Institutional shareholders

43.79%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202358.88m11.01%
Capital Research & Management Co. (World Investors)as of 31 Dec 202329.15m5.45%
Fidelity Management & Research Co. LLCas of 31 Dec 202326.08m4.88%
BlackRock Fund Advisorsas of 31 Dec 202324.19m4.52%
SSgA Funds Management, Inc.as of 31 Dec 202323.14m4.33%
Wellington Management Co. LLPas of 31 Dec 202320.20m3.78%
Norges Bank Investment Managementas of 31 Dec 202317.86m3.34%
Politan Capital Management LPas of 31 Dec 202312.14m2.27%
Swedbank Robur Fonder ABas of 29 Feb 202411.71m2.19%
Harris Associates LPas of 31 Dec 202310.86m2.03%
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.